August 31, 2016 12:18 AM ET

Biotechnology

Company Overview of Gilead Sciences Inc.

Executive Profile

David L. Gollaher Ph.D.

Member of Health Policy Advisory Board, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. David L. Gollaher, Ph.D. served as the Chief Executive Officer and President of California Life Sciences Association (also known as California Healthcare Institute). Dr. Gollaher joined California Healthcare Institute in 1993. He served as Vice President of Scripps Clinic and Research Foundation, with responsibility for clinical operations, business development and managed care. He served on the faculties of Harvard, UCSD and the Graduate School of Public Health ...

Corporate Headquarters

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Harvard University
Master's Degree
Harvard University
Bachelor's Degree
University of California, Santa Barbara

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$1.3M
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Olivier Brandicourt M.D.Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
$2.4M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Gilead Sciences Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.